These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2180103)

  • 1. [Problems with long-term immunosuppression following organ transplantation].
    Thiel G; Landmann J; Mihatsch M
    Ther Umsch; 1990 Feb; 47(2):138-46. PubMed ID: 2180103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Skin diseases in organ transplant patients].
    Ulrich C; Christophers E; Sterry W; Meyer T; Stockfleth E
    Hautarzt; 2002 Aug; 53(8):524-33. PubMed ID: 12221466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious disease considerations in pediatric organ transplantation.
    Deen JL; Blumberg DA
    Semin Pediatr Surg; 1993 Nov; 2(4):218-34. PubMed ID: 8062043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-lymphoid cancer after liver transplantation.
    Frezza EE; Fung JJ; van Thiel DH
    Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppression--a tightrope walk between iatrogenic harm and therapy].
    Berchtold P; Seitz M
    Schweiz Med Wochenschr; 1996 Sep; 126(38):1603-9. PubMed ID: 8927965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous complications after organ transplantation].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3789-92. PubMed ID: 10574059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications of immunosuppression].
    Thiel G; Bock A; Landmann J; Mihatsch M
    Klin Monbl Augenheilkd; 1993 May; 202(5):479-84. PubMed ID: 8377421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin lesions in renal transplant recipients].
    Myśliwiec H; Chodynicka B; Serwin AB
    Wiad Lek; 2002; 55(3-4):214-20. PubMed ID: 12182007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?
    Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B
    Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches towards individualized immune intervention.
    Giese T; Sommerer C; Zeier M; Meuer S
    Dig Dis; 2010; 28(1):45-50. PubMed ID: 20460889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infectious complications due to immunosuppression in organ transplant patients].
    Morelon E; Touraine JL
    Rev Prat; 2007 Oct; 57(15):1677-86. PubMed ID: 18080426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.
    Rifai K; Kirchner GI; Bahr MJ; Cantz T; Rosenau J; Nashan B; Klempnauer JL; Manns MP; Strassburg CP
    Liver Transpl; 2006 Mar; 12(3):411-5. PubMed ID: 16456830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression following cardiac transplantation.
    Woodley SL; Renlund DG; O'Connell JB; Bristow MR
    Cardiol Clin; 1990 Feb; 8(1):83-96. PubMed ID: 2407363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation.
    Dunn DL
    Crit Care Clin; 1990 Oct; 6(4):955-77. PubMed ID: 2265389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer in organ transplanted patients].
    Pfeffer PF
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3792-4. PubMed ID: 10574060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.